Literature DB >> 7440554

Structural characterization of the phosphorylation sites of human erythrocyte spectrin.

H W Harris, S E Lux.   

Abstract

The phosphorylation sites of spectrin dimer were characterized before and after incubation of intact human red cells with [32P]orthophosphate. Phosphate measurements of unlabeled spectrin dimer show it contains 4.0 +/- 0.3 covalent protein phosphates, all located on band 2. Quantitation of the number of exchangeable phosphorylation sites in erythrocytes labeled with [32P]orthophosphate yields 3.9 +/- 0.3 phosphates/spectrin dimer, indicating that all four spectrin phosphorylation sites are metabolically active. Tryptic and chymotryptic peptide mapping reveals that the dimer contains three unique 32P-labeled tryptic peptides of approximately 4,600 (A1), 3,500 (A2), and 2,400 (B) daltons. Peptide A1 contains both phosphoserine and phosphothreonine while peptides A2 and B possess only phosphoserine. Peptides A1 and A2 remain associated after trypsinization of spectrin dimer and are only separable in detergents. All three 32P-labeled tryptic peptides are contained within a 20,000 dalton cyanogen bromide fragment which is within a 60,000 dalton staphylococcal protease phosphopeptide. All these fragments are found within a 90,000 dalton nitrothiocyanobenzoic acid phosphopeptide. The purified 20,000 dalton fragment contains no homoserine or homoserine lactone and is the COOH-terminal cyanogen bromide peptide of band 2. The isolated tryptic peptide B possesses no lysine or arginine and is presumably the COOH-terminal tryptic peptide of band 2 and the most distal phosphopeptide. Thus, the four phosphorylation sites of spectrin dimer are clustered at the extreme COOH-terminal end of band 2.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7440554

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Spectrin Rouen (beta 220-218), a novel shortened beta-chain variant in a kindred with hereditary elliptocytosis. Characterization of the molecular defect as exon skipping due to a splice site mutation.

Authors:  M Garbarz; W T Tse; P G Gallagher; C Picat; M C Lecomte; F Galibert; D Dhermy; B G Forget
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 2.  Role of the phosphorylation of red blood cell membrane proteins.

Authors:  P Boivin
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

3.  Spectrin beta-chain variant associated with hereditary elliptocytosis.

Authors:  D Dhermy; M C Lecomte; M Garbarz; O Bournier; C Galand; H Gautero; C Feo; N Alloisio; J Delaunay; P Boivin
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

Review 4.  The red cell membrane and its cytoskeleton.

Authors:  W B Gratzer
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

5.  Absence of phosphorylation-induced gelation of erythrocyte membrane skeletons: a diagnostic tool for hereditary spherocytosis.

Authors:  R Armbrust; S W Eber; W Schröter
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

6.  Analysis of the red cell membrane in a family with hereditary elliptocytosis--total or partial of protein 4.1.

Authors:  N Alloisio; E Dorléac; R Girot; J Delaunay
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  Abnormal oxidant sensitivity and beta-chain structure of spectrin in hereditary spherocytosis associated with defective spectrin-protein 4.1 binding.

Authors:  P S Becker; J S Morrow; S E Lux
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

8.  Dystrophin is phosphorylated by endogenous protein kinases.

Authors:  M Luise; C Presotto; L Senter; R Betto; S Ceoldo; S Furlan; S Salvatori; R A Sabbadini; G Salviati
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

9.  The murine mutation jaundiced is caused by replacement of an arginine with a stop codon in the mRNA encoding the ninth repeat of beta-spectrin.

Authors:  M L Bloom; T M Kaysser; C S Birkenmeier; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

10.  Heterogeneous phosphorylation of erythrocyte spectrin beta chain in intact cells.

Authors:  S Pedroni; M C Lecomte; H Gautero; D Dhermy
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.